ACETO Corp (ACET) Tops Q1 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
ACETO Reports Fiscal 2016 First Quarter Results
November 5, 2015 5:00 PM ESTPORT WASHINGTON, N.Y., Nov. 5, 2015 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq: ACET), focused on the global marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, announced today financial results for the first quarter of fiscal 2016 ended September 30, 2015.
First Quarter Fiscal 2016 versus First Quarter Fiscal 2015
Net sales of $133.5 million versus $130.8 million, a 2.1% increase Gross profit of $34.6 million versus $27.7 million, a 25.1% increase Net income of $9.3 million versus $4.8 million, a 92.6% increase Diluted EPS of $0.32 versus $0.17, an 88.2% increase Non-GAAP Adjusted Net Income of $11.0 million versus $6.6 million, a 66.4%... More